Office of the Commissioner of Lobbying of Canada
Registry of Lobbyists

Monthly Communication Report

360616-648459

Organization: Novo Nordisk Canada Inc.
Associated registration: 954988-360616-21
Communication date: 2025-10-07
Posted date: 2025-11-15

Designated Public Office Holders who participated in the communication: Sonia Sidhu, Member of Parliament
House of Commons
 
List of Details
Subject matter Detail
Health Advocate for the implementation of a federal diabetes and obesity strategy.
Health Bill C-64, the Pharmacare Act, with respect to definitional questions related to terms contained in Section 6.1, and concerns regarding the increased risk of drug shortages.
Health, International Trade Communication around existing drug shortages and shared solutions to mitigate the impact on Canadians.
 
Responsible Officer who filed this communication report: Vince Lamanna
 
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication.

The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
 

Date Modified: